Point electro-cauterization versus holmium laser cauterization in the treatment of post-ejaculation hematuria.
- Author:
Chun-Hui LIU
1
;
Yi-Ming YUAN
2
;
Zhi-Chao ZHANG
2
;
Wei-Lin PU
3
;
Zhi-Qiang WANG
1
;
Shao-Jun LI
3
;
Chen ZHU
1
;
Hai WANG
1
;
Wen-Sheng SHAN
1
Author Information
1. Department of Andrology, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, Gansu 730050, China.
2. Center of Andrology, Peking University First Hospital, Beijing 100034, China.
3. Department of Reproductive Medicine and Urology, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, Gansu 730050, China.
- Publication Type:Journal Article
- Keywords:
anxiety;
holmium laser;
point electrode;
urinary flow rate;
postejaculation hematuria
- MeSH:
Adult;
Cautery;
Ejaculation;
Hematuria/surgery*;
Holmium;
Humans;
Laser Therapy;
Lasers, Solid-State/therapeutic use*;
Male;
Middle Aged;
Treatment Outcome;
Young Adult
- From:
National Journal of Andrology
2020;26(10):888-894
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the advantages and disadvantages of point electro-cauterization (PEC) and holmium laser cauterization (HLC) in the treatment of post-ejaculation hematuria.
METHODS:From January 2015 to December 2018, 73 patients with post-ejaculation hematuria, aged 24－63 (36.8 ± 4.2) years, underwent PEC (n = 35) or HLC (n = 38) after failure to respond to 3 months of conservative treatment. We compared the hospital days, total hospitalization expenses, maximum urinary flow rate (Qmax), average urinary flow rate (Qavg), Hamilton Anxiety Rating Scale (HAMA) score, postoperative duration of hematuria, and recurrence rate at 3 and 6 months after surgery.
RESULTS:All the patients experienced first ejaculation but no post-ejaculation hematuria at 1 month after operation. The recurrence rates were lower in the PEC than in the HLC group at 3 months (5.71% vs 2.63%, P > 0.05) and 6 months postoperatively (8.57% vs 5.26%, P > 0.05). Compared with the baseline, the Qmax was decreased from (18.56 ± 2.53) ml/s to (13.68 ± 3.31) ml/s (P < 0.05) and the Qavg from (14.35 ± 2.26) ml/s to (9.69±1.84) ml/s in the PEC group at 1 month after surgery (P < 0.01), but neither showed any statistically significant difference in the HLC group. Mild to moderate anxiety was prevalent in the patients preoperatively, particularly in those without job or regular income and those with a long disease course or frequent onset, the severity of which was not correlated with age, education or marital status. The HAMA score was decreased from18.65 ± 4.33 before to 12.35 ± 3.63 after surgery in the PEC group (P < 0.01), and from 16.88 ± 2.11 to 6.87 ± 4.36 in the HLC group (P < 0.01). The mean hospital stay was significantly longer in the former than in the latter group (［5.2 + 1.3］ vs ［3.4 ± 0.5］ d, P < 0.01), while the total cost markedly lower (［6.35 ± 1.20］ vs ［12.72 ± 2.15］ thousand RMB ¥, P < 0.05).
CONCLUSIONS:Both PEC and HLC are safe and effective for the treatment of post-ejaculation hematuria, with no significant difference in the recurrence rate at 3 and 6 months after operation, but their long-term effect needs further follow-up studies. PEC may increase the risk of negative outcomes of the postoperative urinary flow rate, while HLC has the advantages of better relieving the patient's anxiety, sooner discharge from hospital and earlier recovery from postoperative hematuria, though with a higher total cost than the former.
